LMDX - Earnings announcements

LONDON, Aug. 24, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (NASDAQ:LMDX), a next-generation point of care (POC) diagnostics company, today announced financial results for its second quarter ended June 30, 2023. Second quarter 2023 revenues of $21.0 millionSubmitted First 510(k) Application to the U.S. Food and Drug Administration (FDA) for 5-minute COVID Ultra testSubmitted COVID/Flu combo test for FDA Emergency Use Authorization (EUA) as part of the NIH's Independent Test Assessment (ITAP) programMore than 1,500 new instruments shipped in Q2, primarily to U.S. pharmacy locations to expand testing capacity for the upcoming respiratory season Ron Zwanziger, Chairman and CEO of LumiraD

LONDON, Aug. 16, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited  (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, announced it will release its second quarter financial results on Thursday, August 24, 2023. On the day of the release, LumiraDx will host a conference call and webcast at 8:30 AM Eastern Time to review the financial results and business highlights.    LumiraDx Second Quarter 2023 Financial Results Conference Call  Date:Thursday, August 24, 2023Time:8:30 AM Eastern Time   Live Call/Webcast:   Register to join by phone here.  View webcast: https://investors.lumiradx.com/news-and-events/investor-calendar    A replay of the webcast will be available on the Inv

LONDON, May 16, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (NASDAQ:LMDX), a next-generation point of care (POC) diagnostics company, today announced financial results for its first quarter ended March 31, 2023. First quarter 2023 revenues of $22.2 million.Cost reduction programs implemented across the global organization resulting in declining operating losses.US Clinical Studies for first 510K submission completed.More than 100 customers in the first full launch quarter for the world's first quantitative finger stick NT-proBNP assay. Ron Zwanziger, Chairman and CEO of LumiraDx, stated, "Our transition to non-COVID is beginning to develop, especially with the commercial launches of HbA1c

LONDON, May 09, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited  (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, announced it will release its first quarter financial results on Tuesday, May 16th, 2023. On the day of the release, LumiraDx will host a conference call and webcast at 8:30 AM Eastern Time to review the financial results and business highlights.  LumiraDx First Quarter 2023 Financial Results Conference Call  Date:Tuesday, May 16, 2023Time:8:30 AM Eastern TimeLive Call/Webcast:   Register to join by phone here.    View webcast: https://investors.lumiradx.com/news-and-events/investor-calendar   A replay of the webcast will be available on the Investors sectio

LONDON, March 21, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (NASDAQ:LMDX), a next-generation point of care (POC) diagnostics company, today announced financial results for its fourth quarter and full year ended December 31, 2022. Full year 2022 revenues of $254.5 million.Q4 2022 revenue of $41.1 million compared to Q3 2022 revenue of $42.2 million; strong position in a changing COVID testing market.Increased our installed base by more than 1,500 Platform instruments, primarily in Europe, driven by new product sales in diabetes, inflammation, heart failure and respiratory disease. Demonstrating Platform consolidation strategy in UK and Germany.        Commenced commercial shipments of

LONDON, March 14, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, announced it will release its fourth quarter and full year 2022 financial results on Tuesday, March 21st, 2023. On the day of the release, LumiraDx will host a conference call and webcast at 8:30 AM Eastern Time to review the financial results and business highlights.  LumiraDx Fourth Quarter and Full Year 2022 Financial Results Conference Call  Date:Tuesday, March 21, 2023Time:8:30 AM Eastern TimeLive Call/Webcast:Register to join by phone here.   View webcast:https://investors.lumiradx.com/news-and-events/investor-calendar A replay of the webcast will b

LONDON, Nov. 09, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (NASDAQ:LMDX), a next-generation point of care (POC) diagnostics company, today announced operational and financial results for the third quarter ended September 30, 2022. Q3 2022 revenue of $42.2 million compared to Q2 2022 revenue of $44.7 million and Q3 2021 revenue of $109.1 million; strong position in a changing COVID testing marketGlobal restructuring plan on track with cost-saving initiatives implemented of $18 million per quarterCommercializing newly CE marked products in Europe and international markets: HbA1c, NT-ProBNP, SARS-CoV-2 Ag Ultra, Ultra Pool, and SARS-CoV-2 & RSV comboDiabetes test shipments commence

LONDON, Nov. 02, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited  (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, announced it will release its third quarter financial results on Wednesday, November 9th, 2022. On the day of the release, LumiraDx will host a conference call and webcast at 8:00 AM Eastern Time to review the financial results and business highlights.  LumiraDx Third Quarter 2022 Financial Results Conference CallDate:Wednesday, November 9, 2022Time:8:00 AM Eastern Time   Live Call/Webcast:   Register to join by phone here.    View webcast: https://investors.lumiradx.com/news-and-events/investor-calendar  A replay of the webcast will be available on the Inv

LONDON, Aug. 11, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited  (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, announced it will release its second quarter financial results on Thursday, August 18th, 2022. On the day of the release, LumiraDx will host a conference call and webcast at 8:00 AM Eastern Time to review the financial results and business highlights.  LumiraDx Second Quarter 2022 Financial Results Conference CallDate:Thursday, August 18, 2022Time:8:00 AM Eastern Time   Live Call/Webcast:   Register to join by phone here.https://investors.lumiradx.com/news-and-events/investor-calendar  A replay of the webcast will be available on the Investor's section of t

Strong Growth in Instruments Delivered to Customers and Continued Innovation on our Platform LONDON, May 11, 2022 /PRNewswire/ -- LumiraDx Limited (NASDAQ:LMDX), a next-generation point of care (POC) diagnostics company, today announced financial and operational results for the first quarter ended March 31, 2022. For the first three months of 2022, LumiraDx revenue was $126.4 million compared to $106.9 million for the first quarter of 2021Customer install base grew to 25,000 Platforms compared to 21,000 at year-end 2021, lead by new instrument placements with U.S. customersQ1

LONDON, April 29, 2022 /PRNewswire/ -- LumiraDx Limited  (NASDAQ:LMDX), a next-generation point of care (POC) diagnostics company, announced it will release its first quarter financial results on Wednesday, May 11, 2022. On the day of the release, LumiraDx will host a conference call and webcast at 4:30 PM Eastern Time to review the financial results and business highlights. Event: LumiraDx First Quarter 2022 Financial Results Conference Call Date: Wednesday, May 11, 2022 Time: 4:30 PM Eastern Time    Live Call/Webcast:    (877) 270-2148 (Domestic), (412) 902-6510 (Internation

LONDON, March 10, 2022 /PRNewswire/ -- LumiraDx Limited (NASDAQ:LMDX), a next-generation point of care (POC) diagnostics company, today announced financial and operational results for the fourth quarter and full year ended December 31, 2021. Full year 2021 revenues of $421.4 million up from full year 2020 revenue of $139.2 million, as the pandemic accelerated momentum on our long-term growth strategy Fourth quarter 2021 revenue of $118.3 million rose sequentially compared to strong Third Quarter 2021 revenue of $109.1 million and year over year versus fourth quarter 2020 reven

LONDON, March 3, 2022 /PRNewswire/ -- LumiraDx Limited  (NASDAQ:LMDX), a next-generation point of care (POC) diagnostics company, announced it will release its fourth quarter and full year 2021 financial results on Thursday, March 10, 2022. On the day of the release, LumiraDx will host a conference call and webcast at 8 AM Eastern Time to review the financial results and business highlights. Event: LumiraDx Fourth Quarter 2021 Financial Results Conference Call Date: Thursday, March 10, 2022 Time: 8:00 AM Eastern Time    Live Call/Webcast: (844) 224-4100 (Domestic), (215)

LONDON, Nov. 10, 2021 /PRNewswire/ -- LumiraDx (NASDAQ:LMDX), a next-generation point of care (POC) diagnostics company, today announced financial results for the quarter ended September 30, 2021. Revenue of $109.1M for the three months ended Sept. 30, 2021 and $303.2M for the nine months ended Sept. 30, 2021 rose significantly over revenue of $139.2M for the twelve months ended Dec. 31, 2020 on strong traction for our long-term strategy Platform revenue driven by higher COVID testing rates in all markets, especially U.S.; uptick in Europe for COVID Ag Pool tests enabling high

LONDON, Nov. 2, 2021 /PRNewswire/ -- LumiraDx  (NASDAQ:LMDX), a next-generation point of care (POC) diagnostics company, announced it will release its third quarter 2021 financial results on Wednesday, November 10, 2021. On the day of the release, LumiraDx will host a conference call and webcast at 8 AM Eastern Time to review the financial results and business highlights. Event: LumiraDx Third Quarter 2021 Financial Results Conference Call Date: Wednesday, November 10, 2021 Time: 8:00 AM Eastern Time    Live Call/Webcast: (844) 224-4100 (Domestic), (215) 372-9500 (Inter